Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
19
pubmed:dateCreated
1999-10-14
pubmed:abstractText
HIV infection is accompanied by an early immune dysfunction limiting host control of virus and likely contributing to difficulties in achieving a successful vaccine against HIV. We report here that the HIV Tat protein is strongly immunosuppressive, both immediately after immunization of mice with soluble protein (sTat), and in seroconverting humans, and propose that Tat-induced suppression cripples immune surveillance to HIV infection. We show that macrophages are sensitive to sTat stimulation at concentrations 1,000-fold lower (500 pM) than T cells, and this stimulation is accompanied by the immunosuppressive induction of Fas ligand on the macrophage. T cell proliferative defects induced by sTat in vitro can be completely (at lower concentrations of sTat) or partially (at higher concentrations) reversed by antagonists to Fas/Fas ligand interaction. We further report a method to preserve immunogenicity while inactivating Tat immunosuppression through oxidation, which advances the use of oxidized Tat as a component of an anti-HIV vaccine. These observations define additional methods to study the immunosuppressive functions of sTat that now may be rapidly applied to primary isolates from individuals with differing clinical courses. Our findings have immediate relevance for vaccine development, by describing and supporting a strategy that includes inactivated sTat in a multicomponent, anti-HIV vaccine.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/10485913-1346269, http://linkedlifedata.com/resource/pubmed/commentcorrection/10485913-1373758, http://linkedlifedata.com/resource/pubmed/commentcorrection/10485913-1402655, http://linkedlifedata.com/resource/pubmed/commentcorrection/10485913-1600383, http://linkedlifedata.com/resource/pubmed/commentcorrection/10485913-1713127, http://linkedlifedata.com/resource/pubmed/commentcorrection/10485913-2556795, http://linkedlifedata.com/resource/pubmed/commentcorrection/10485913-2849510, http://linkedlifedata.com/resource/pubmed/commentcorrection/10485913-7494270, http://linkedlifedata.com/resource/pubmed/commentcorrection/10485913-7530335, http://linkedlifedata.com/resource/pubmed/commentcorrection/10485913-7530336, http://linkedlifedata.com/resource/pubmed/commentcorrection/10485913-7530337, http://linkedlifedata.com/resource/pubmed/commentcorrection/10485913-7537511, http://linkedlifedata.com/resource/pubmed/commentcorrection/10485913-7539892, http://linkedlifedata.com/resource/pubmed/commentcorrection/10485913-7612232, http://linkedlifedata.com/resource/pubmed/commentcorrection/10485913-7716549, http://linkedlifedata.com/resource/pubmed/commentcorrection/10485913-8096089, http://linkedlifedata.com/resource/pubmed/commentcorrection/10485913-8228347, http://linkedlifedata.com/resource/pubmed/commentcorrection/10485913-8455722, http://linkedlifedata.com/resource/pubmed/commentcorrection/10485913-8513493, http://linkedlifedata.com/resource/pubmed/commentcorrection/10485913-8666922, http://linkedlifedata.com/resource/pubmed/commentcorrection/10485913-8782444, http://linkedlifedata.com/resource/pubmed/commentcorrection/10485913-8991642, http://linkedlifedata.com/resource/pubmed/commentcorrection/10485913-9060635, http://linkedlifedata.com/resource/pubmed/commentcorrection/10485913-9126933, http://linkedlifedata.com/resource/pubmed/commentcorrection/10485913-9223324, http://linkedlifedata.com/resource/pubmed/commentcorrection/10485913-9371641, http://linkedlifedata.com/resource/pubmed/commentcorrection/10485913-9391113, http://linkedlifedata.com/resource/pubmed/commentcorrection/10485913-9420207, http://linkedlifedata.com/resource/pubmed/commentcorrection/10485913-9491887, http://linkedlifedata.com/resource/pubmed/commentcorrection/10485913-9616211, http://linkedlifedata.com/resource/pubmed/commentcorrection/10485913-9641677, http://linkedlifedata.com/resource/pubmed/commentcorrection/10485913-9641684
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
14
pubmed:volume
96
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
10842-7
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:10485913-AIDS Vaccines, pubmed-meshheading:10485913-Animals, pubmed-meshheading:10485913-Cells, Cultured, pubmed-meshheading:10485913-Dose-Response Relationship, Drug, pubmed-meshheading:10485913-Fas Ligand Protein, pubmed-meshheading:10485913-Flow Cytometry, pubmed-meshheading:10485913-Gene Products, tat, pubmed-meshheading:10485913-HIV Infections, pubmed-meshheading:10485913-Humans, pubmed-meshheading:10485913-Immune Tolerance, pubmed-meshheading:10485913-Immunoblotting, pubmed-meshheading:10485913-Leukocytes, Mononuclear, pubmed-meshheading:10485913-Macrophages, pubmed-meshheading:10485913-Membrane Glycoproteins, pubmed-meshheading:10485913-Mice, pubmed-meshheading:10485913-Mice, Inbred BALB C, pubmed-meshheading:10485913-Recombinant Proteins, pubmed-meshheading:10485913-T-Lymphocytes, Helper-Inducer, pubmed-meshheading:10485913-tat Gene Products, Human Immunodeficiency Virus
pubmed:year
1999
pubmed:articleTitle
Pronounced acute immunosuppression in vivo mediated by HIV Tat challenge.
pubmed:affiliation
Dermatology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't